Retraction

BEBT-908: A novel potent PI3K/HDAC inhibitor against diffuse large B-cell lymphoma

Paper Information

Record ID:
17460
Author(s):
Jin Li
Changgeng Qian
Qianqian Zhou
Jiwei Li
Kunlun Li
Pingyong Yi
Journal:
Biochemical and Biophysical Research Communications (BBRC) ( Elsevier )
Publication Date:
July 26, 2017
Retraction Date:
February 23, 2018 (7.7 years years ago)
Subjects:
Broad Categories:
Biology Genetics
Institutions:
Country:
🇨🇳 China
Article Type:
Research Article
Publisher:
Elsevier
Open Access:
Yes
DOI:
10.1016/j.bbrc.2017.07.139
PubMed ID:
28756223
Retraction PubMed ID:
29530244

Retraction Details

Retraction Reasons:
Nature of Retraction:

Retraction

Retraction Notice:
10.1016/j.bbrc.2018.03.006

Citations (2)

2
Total Citations
2
Post-Retraction
(100.0%)
0
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
0 Within 1 year
1 After 2+ years
1050 Days since retraction (latest)
Paper citing BEBT-908: A novel potent PI3K/HDAC inhibitor again...
Unknown Authors
Unknown Journal
Published: Jan 2021
1050 days after retraction
Paper citing BEBT-908: A novel potent PI3K/HDAC inhibitor again...
Unknown Authors
Unknown Journal
Published: May 2019
459 days after retraction
Quick Stats
Total Citations: 2
Years Since Retraction: 7.7 years
Open Access: Yes
Last Checked: Never
Related Papers
miR-129-2-3p inhibits colon cancer cell proliferation by do…
Arab Journal of Gastroenterology • 12 citations
The Predictive Efficacy of Programmed Cell Death in Immunot…
Environmental Toxicology • 6 citations
Silencing of Long Noncoding RNA LINC00346 Inhibits the Tumo…
OncoTargets and Therapy • 15 citations
miR-34a inhibits melanoma growth by targeting ZEB1
Aging • 28 citations
miR-129-5p suppresses proliferation, migration, and induces…
Acta Biochimica et Biophysica Sinica • 25 citations
Actions
More from this journal Similar subjects View Original Paper View Retraction Notice